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Most cell surface and secreted proteins are glycosylated -that is, they have one or more oligosaccharide chains covalently attached to specific amino acids. These oligosaccharides usually make up a significant amount of the hydrodynamic mass of the molecules and also have effects on protein conformation, surface expression, stability, circulating half life, activity, and antigenicity. In addition, oligosaccharide sequences are themselves recognised as antigens and as ligands for carbohydrate binding proteins (lectins). The immune system exemplifies the diversity of oligosaccharide structure and function, which this review will aim to communicate. In particular, the relevance of oligosaccharide heterogeneity, antigenicity, and immune regulatory activity in autoimmunity and microbial pathogenesis will be considered. Firstly, a general description of the structure and three dimensional arrangement of protein glycosylation will be given. Then, we describe the structure of the major glycoprotein effector molecules involved in immune regulation and concentrate on the role of T cell -y 8 cells in tuberculosis and rheumatoid arthritis (RA).
General description of protein glycosylation (also see Glossary) Protein glycosylation is of two major types called N-or 0-linked depending on the linkage of the oligosaccharide chain through asparagine (NH2) or serine/threonine (OH), respectively. N-linked chains typically have a pentasaccharide core of mannose (Man) and N-acetylglucosamine (GlcNAc) residues with additional mannose residues (high mannose chains) or backbone galactose-N-acetylglucosamine sequences with and without chain terminating sialic acid residues (complex chains). Hybrid chains are defined as those having some high mannose branches and some complex-type sequences. The core and backbone residues of complex chains are variously decorated with blood group and related antigenic sequences involving substitution with fucose, (Fuc), N-acetylgalactosamine (GalNAc), and galactose (Gal).' 2 The presence of the different chains can be distinguished not only by chemical composition but also by their susceptibility to enzyme digestion -all are released by peptide-N-glycosidase F, whereas endoglycosidase H only releases high mannose chains.
0-linked glycosylation discussed in this article is characterised by core regions based on N-acetylgalactosamine linked to protein, with galactose, N-acetylglucosamine, or N-acetylgalactosamine attached. 1-Extension of the chains is by substitution patterns similar to those of the outer branches of N-linked glycosylation (although there are differences). In both chains the diversity of oligosaccharide sequences is manifest in the large number of ways the monosaccharides can be linked together (that is, through 1-4 hydroxyl groups, with and without branching, in (x or 3 configuration, etc). Each linkage has a particular set of allowed conformations in solution which provide specific orientations of functional groups for molecular recognition. Such epitopes usually extend over a tri-to heptasaccharide sequence, but topographical epitopes caused by folding back of long carbohydrate chains onto themselves or onto protein are possible. In addition, the oligosaccharide cores of 0-linked chains are in close association with the protein backbone, which strongly influences protein conformation and oligosaccharide-protein antigenicity.' Often multiple 0-glycosylation sites are clustered in one region of the protein to accentuate these conformational effects (for example, CD8 discussed below).
N-linked chains are in general less stereochemically restricted around the proteinoligosaccharide linkage than their 0-linked counterparts, and, in addition, have considerable flexibility at branch points within the chain. The oligosaccharide moieties, therefore, sample a large amount of conformational space, but in some cases they may be restrained by interaction with the protein backbone or adjacent oligosaccharides attached to the same protein. 
Conclusion
Study of the possible role of superantigens in autoimmune disorders has recently become the vogue. Care should be exerted in interpretation of the data, however, owing to the complexity of the interactions of the effector molecules involved in immune regulation. An important aspect of these interactions is the role of glycosylation in regulating glycoprotein activity, antigenicity, and recognition. Protein glycosylation may be involved in several stages in the aetiology of RA: (a) initiating antigen; (b) control of T cell interactions; (c) control of antibody function; (d) microvasculature breakdown; (e) breakdown of synovial gel/water structure; and () specific signals to inflammatory cells.
Of crucial importance is the role that proteoglycan sequences have in maintaining the endothelial cell surface barrier, the physicochemical properties of the synovium, and cartilage structure. The release of enzymes which breakdown these proteoglycans could also directly affect lymphocyte immune function by altering cell surface molecules and intracellular trafficking. Peptidoglycan: Repeating bacterial cell wall polymer of amino acids, muramic acid, and N-acetylglucosamine. 
